• / Free eNewsletters & Magazine
  • / My Account
Home>Novo Nordisk stock rises on $2 billion buyback

Novo Nordisk stock rises on $2 billion buyback

3party Content

Mon, 26 Jan 2015

Shares of Novo Nordisk (NVO) gained 2.5% in premarket trade Monday after the drug manufacturer announced a new share buyback plan of up to 15 billion Danish Krone ($2.2 billion). Stock repurchases will be made over the next 12 months. Shares of Denmark-based Novo, which makes a suite of diabetes
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.